ACB $8.710 (-5.63%)

ACNNF $0.092 (1.1%)

AERO $2.945 (-0.51%)

AGEEF $0.043 (-6.74%)

ALEAF $0.379 (-0.12%)

AMMJ $0.086 (-3.93%)

APHA $7.010 (2.34%)

ARNA $65.500 (0.17%)

ATT:CNX $0.080 (0%)

ATTBF $0.007 (-3.7%)

AUSA:CNX $0.205 (2.5%)

AUSAF $0.152 (1.47%)

AVXL $5.200 (5.05%)

BAMM:CNX $0.435 (2.35%)

BBM:CNX $0.050 (0%)

BBRRF $0.042 (18.23%)

BE:CNX $0.005 (0%)

BIO:CNX $0.030 (0%)

BLEVF $0.003 (30.43%)

BLIS:CNX $0.315 (0%)

BLO:CNX $0.600 (1.69%)

BLOZF $0.442 (-2.57%)

BUDZ $0.245 (2.08%)

BXNG $0.400 (0%)

CADMF $0.300 (3.79%)

CALI:CNX $0.055 (0%)

CANN $0.490 (13.95%)

CARA $15.050 (-0.73%)

CBII:CNX $0.510 (13.33%)

CBIIF $0.352 (-2.36%)

CBWTF $0.229 (-0.65%)

CGC $26.870 (-0.37%)

CGRW $0.100 (7.99%)

CHOO:CNX $0.070 (0%)

CHOOF $0.055 (0%)

CNBX $0.270 (-3.66%)

CNGGF $0.427 (15.46%)

CODI $19.690 (0.1%)

CPMD $0.370 (-5.13%)

CRBP $1.200 (-1.64%)

CRON $7.970 (-0.62%)

CROP:CNX $0.015 (0%)

CRTPF $1.895 (1.03%)

CRXPF $0.026 (-0.77%)

CSI:CNX $0.920 (0%)

CURR $1.039 (-1.05%)

CVSI $0.430 (-6.93%)

DIGP $0.018 (-2.17%)

DXBRF $0.080 (-15.89%)

EAPH $0.001 (0%)

EAT:CNX $0.005 (0%)

EEVVF $0.059 (0.08%)

EMHTF $0.180 (-2.04%)

EPWCF $0.061 (-0.25%)

EVIO $0.003 (31.58%)

FFRMF $0.032 (18.64%)

FFT:CNX $0.040 (0%)

FNNZF $0.037 (-2.36%)

GGTTF $0.102 (2%)

GLDFF $0.024 (17.5%)

GLH:CNX $0.025 (0%)

GNBT $0.202 (0.55%)

GRIN:CNX $0.105 (-4.55%)

GRWG $33.530 (1.88%)

GTBIF $20.400 (4.4%)

GTII:CNX $26.960 (1.74%)

GWPH $127.610 (-1.33%)

HEXO $0.790 (-1.15%)

HLSPY $0.316 (-3.51%)

HMLSF $6.257 (-0.12%)

HMPPF $0.498 (0%)

HRVOF $0.051 (2.8%)

HSTRF $0.092 (-4.85%)

HUGE:CNX $1.800 (-4.26%)

IAN:CNX $0.150 (11.11%)

IGC $1.460 (-1.35%)

IGXT $0.267 (-1%)

IIPR $156.280 (1.07%)

INQD $0.001 (-8.33%)

IONC:CNX $0.015 (0%)

IONKF $0.015 (-6.15%)

ISOL:CNX $0.020 (-20%)

ISOLF $0.018 (-12.08%)

ITHUF $0.105 (7.58%)

IVITF $0.020 (-9.09%)

JWCAF $0.004 (58.33%)

KBEV:CNX $0.060 (0%)

KBEVF $0.043 (-8.9%)

KHRNF $0.360 (1.98%)

KSHB $0.750 (-2.6%)

LHS:CNX $0.495 (-1%)

LHSIF $0.380 (5.88%)

LOVE:CNX $0.080 (0%)

LXRP $0.197 (1.47%)

LXX:CNX $0.270 (8%)

MCIG $0.028 (0%)

MEDIF $0.413 (-2.43%)

MGWFF $0.043 (-8.33%)

MICWF $0.099 (5.49%)

MJ:CNX $0.090 (12.5%)

MJNA $0.018 (-1.09%)

MNTR $0.095 (1.61%)

MRRCF $0.003 (-6.25%)

MWM:CNX $0.115 (-8%)

MYM:CNX $0.050 (0%)

MYMMF $0.046 (-3.19%)

NCNNF $0.126 (0.01%)

NDVAF $0.167 (11.3%)

NGW:CNX $0.350 (-2.78%)

NRXCF $0.096 (0%)

NSPDF $0.032 (-12.05%)

NTEC $3.040 (1.33%)

NWKRF $0.424 (0%)

NXGWF $0.279 (-1.41%)

NXTTF $0.171 (-1.61%)

OH:CNX $5.330 (0%)

ORHOF $4.050 (0%)

OWCP $0.012 (25.53%)

PHCG $0.380 (-5.95%)

PHVAF $0.038 (0%)

PILL:CNX $0.650 (-2.99%)

PKG:CNX $0.085 (-5.56%)

PLPRF $0.440 (4.76%)

PLUS:CNX $0.550 (0%)

PMCB $0.006 (1.72%)

PNPL $0.110 (0%)

POTN $0.006 (-9.68%)

PRCNF $0.004 (-55%)

PTNYF $0.072 (27.44%)

QCA:CNX $0.105 (5%)

RDDTF $0.071 (-6.36%)

RLLVF $0.029 (0%)

RMHB $0.045 (-7.79%)

RQB:CNX $0.005 (0%)

RQHTF $0.203 (4.11%)

RVVQF $0.007 (54.47%)

SLNG:CNX $0.295 (5.36%)

SMG $168.790 (-0.68%)

SNN:CNX $0.155 (0%)

SNNVF $0.075 (-11.76%)

SOL:CNX $2.490 (5.96%)

SOLCF $1.810 (9.01%)

SPLIF $0.006 (15.38%)

SPRWF $0.106 (-2.75%)

SRNA $0.029 (1.75%)

STEM:CNX $0.480 (-9.43%)

STMH $0.430 (-2.82%)

SUN:CNX $0.150 (0%)

TBPMF $0.140 (1.75%)

TCAN:CNX $0.780 (0%)

TCNAF $0.566 (-3.92%)

TER:CNX $11.700 (-1.6%)

TGEN $1.280 (-3.76%)

TGIF:CNX $0.075 (7.14%)

TGIFF $0.056 (1.53%)

THC:CNX $0.090 (-5.26%)

THCBF $0.070 (0%)

TLRY $7.470 (-4.6%)

TOKI:CNX $0.015 (0%)

TRLFF $0.065 (-8.6%)

TRSSF $9.150 (17.03%)

TRTC $0.101 (0.5%)

TURV $0.070 (-1.13%)

VBIO $0.120 (0%)

VIDA:CNX $0.055 (0%)

VIN:CNX $0.045 (28.57%)

VPRB $0.017 (0%)

VRNDF $0.435 (-2.8%)

VRT:CNX $0.150 (0%)

VRTHF $0.115 (0%)

VVCIF $0.091 (-0.71%)

WAYL:CNX $0.740 (0%)

WDDMF $0.227 (-0.57%)

WLDFF $0.122 (8.06%)

XXII $1.510 (5.59%)

ZDPY $0.430 (-1.15%)

ZYNE $4.580 (0.66%)

Technical420 Site Search

Returned 95 result(s).

MediPharm Labs Enters New GMP Manufacturing Deal with Sunco Green Pharmaceutical Pty Ltd. in Australia

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced its wholly owned subsidiary, MediPharm Labs Australia Pty Ltd, has entered into a new white-label supply agreement with Sunco Green Pharmaceutical Pty Ltd.. This marks MediPharm Labs’…

MediPharm Labs Achieves First Sales Milestone in Australia, Global Sales for GMP Products Continue to Ramp Up in Q3 2020

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced its Australian operation – MediPharm Labs Australia Pty. Ltd. – has reached its first month operational milestone, with approximately $500,000 AUD, of formulated products delivered to customers in…

Raw Garden Is One Of The Strongest Cannabis Brands In The U.S You Have Probably Never Heard Of

Although 420 (April 20th) is the best-known cannabis holiday, 710 (July 10th) is gaining steam and is quickly becoming one of the best-known holidays in the cannabis industry. For our readers who are unaware of 710 day, it is the day of the year that celebrates cannabis oil. The origination…

Halo Announces Extension of the Binding LOI with Canmart Limited And Provides Update on Positive UK Market Developments

Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) today announces that further to the press releases dated December 24, 2019 and March 3, 2020, the Company has agreed to a second extension of the binding letter of intent (the “LOI”) to acquire all of the…

MediPharm Labs Australia Signs First International White-Label Supply Deal with New Zealand based Helius Therapeutics

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce that its subsidiary, MediPharm Labs Australia Pty Ltd (“MediPharm Labs Australia”), has entered into an agreement to supply pharmaceutical-quality (GMP certified), white-label, cannabis oil products to…

Neptune Announces Sherbrooke Phase II Expansion is Now Operational and Running Product for Customers

Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT), is pleased to announce today that its phase II expansion at its Sherbrooke, Quebec facility is operational and has been approved to run product for customers bringing our capacity to 200,000 kg. "Our first production runs for customers mark a key milestone…

Nextleaf Labs Signs Cannabis Extraction Agreement with 10-acre Greenhouse Cannabis Cultivator

Nextleaf Solutions Ltd. ("Nextleaf Solutions", "OILS", or the "Company") (CSE: OILS) (OTCQB: OILFF), Canada's most innovative cannabis extractor, is pleased to announce that Nextleaf Labs Ltd. ("Nextleaf Labs"), a Health Canada licensed standard processor whose acquisition by OILS is pending, has entered into a Cannabis Extraction Agreement (the "Agreement") with a…

MediPharm Labs Is Looking Very Attractive At Current Levels

The transformation of the Canadian cannabis market with the legalization of 2.0 products is an opportunity that we are excited about over the long-term. Although the market has been less than impressed with the sales numbers that are coming out of Canada, we believe that the long-term opportunity remains intact.…

MediPharm Labs to Supply Medical Cannabis Products to Medical Cannabis by Shoppers

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce Shoppers Drug Mart, Canada’s leading pharmacy retailer, has selected its wholly-owned subsidiary, MediPharm Labs Inc. (“MediPharm”), to supply high-quality…

MediPharm Labs Sets Date to Release Full Year 2019 and Fourth Quarter Financial Results

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in research-driven, pharmaceutical quality cannabis extraction, distillation and derivative product production, announced it will release its audited financial results, within the timelines required by TSX issuers, for the three and twelve months ended…

Older Posts »

Search Again